LIVE
Login☆ WatchlistAPI Docs
Markets
NSE StocksBSE StocksF&ORates & G-SecsCurrenciesSectorsCommodities
News
Corporate AnnouncementsGovernment & PolicyFixed IncomeETFsFXAlt. InvestingEconomic Calendar
Sections
EconomicsTechFinancePoliticsWealth
Language
Englishहिन्दीગુજરાતીमराठी

SAILIFE

NSEBSE
Sai Life Sciences Limited
Healthcare· Pharmaceuticals & Biotechnology· INE570L01029· Scrip: 544306
ENहिन्दीગુજરાતીमराठी
1,064.80
39.85 (+3.89%)
27/4/2026, 3:28:56 pm
NSE
1,064.80
39.85
+3.89%
BSE
958.30
0.00
+0.00%
7017958889811,07505-0206-2708-2510-2312-1902-1804-2704-30
244 trading days · 1Y period
TODAY
Open1,026.80
High1,076.85
Low1,025.85
Prev Close1,024.95
Volume8.54L
Value₹89.4Cr
L: 1,025.85H: 1,076.85
52 WEEK
Low675.40
High1,084.00
95% of 52W range
Info
Face Value₹1
Listed2024-12-18
ISININE570L01029
SeriesA
BSE Scrip544306

Key Metrics

1D
+0.89%
1W
+2.20%
1M
+6.54%
3M
+29.59%
6M
+22.10%
Valuation
Mkt Cap₹20425 Cr
Growth (QoQ)
PAT
EPS

Quarterly Financials

Revenue
EBITDA
PAT
EPS
0 Cr110 Cr220 Cr330 Cr440 Cr24-12
QuarterRevenueExpensesEBITDAPBTPATEPS
2024-12-31440 Cr377 Cr106 Cr72 Cr54 Cr2.89

Shareholding Pattern

CURRENT2026-03-31
34.6%PROMOTER
Promoter34.6%
FII21.2%
DII31.5%
Public65.4%
PROMOTER HOLDING TREND
35.2%24-1235.2%24-1235.2%25-0334.9%25-0934.7%25-1234.6%26-03

Earnings Transcripts

Sai Life Sciences Limited has informed the Exchange about Investor Presentation
7 Nov 2025NSE30K chars
Read →
Sai Life Sciences Limited has informed the Exchange about Schedule of Earnings Conference call for d...
24 Oct 2025NSE4K chars
Read →
Transcript of Earnings Call for the Un-audited Financial Results of the Company for the quarter ende...
18 Aug 2025NSE1K chars
Read →
Recording of Earnings Call for the Un-audited Financial Results of the Company for the quarter ended...
8 Aug 2025NSE1K chars
Read →
Sai Life Sciences Limited has informed the Exchange about Investor Presentation
8 Aug 2025NSE26K chars
Read →
Sai Life Sciences Limited has informed the Exchange about Investor Presentation
14 May 2025NSE17K chars
Read →
Sai Life Sciences Limited has informed the Exchange about Investor Presentation
25 Feb 2025NSE21K chars
Read →
Sai Life Sciences Limited has informed the Exchange about Investor Presentation
7 Feb 2025NSE20K chars
Read →

Price History

DateOpenHighLowCloseVolume
2026-04-301,059.001,089.901,047.501,069.4513.68L
2026-04-291,047.951,078.001,047.951,055.103.84L
2026-04-281,067.651,078.351,044.001,047.952.81L
2026-04-271,026.801,076.851,025.851,067.308.61L
2026-04-241,051.401,054.601,017.001,024.954.58L
2026-04-231,011.801,049.101,011.801,041.608.61L
2026-04-22959.001,014.80955.601,006.007.94L
2026-04-21959.40977.10944.00958.658.36L
2026-04-20973.05978.95953.45959.403.42L
2026-04-17974.00989.70967.60971.053.14L
2026-04-16985.95991.05960.20972.354.03L
2026-04-151,000.001,008.90976.25981.304.10L
2026-04-13989.001,001.55970.30990.703.97L
2026-04-10981.001,009.00976.65999.002.81L
2026-04-09973.05995.85964.25978.106.85L
2026-04-08970.00984.20959.20973.554.10L
2026-04-07945.00955.05927.05945.652.41L
2026-04-02975.90975.90944.05959.956.36L
2026-04-011,000.001,015.20959.45976.856.56L
2026-03-271,010.001,010.00969.70985.859.02L
2026-03-251,006.001,029.80990.151,012.3511.94L
2026-03-241,016.901,020.00986.55999.154.46L
2026-03-201,015.001,019.75995.201,000.053.63L
2026-03-191,002.001,020.50995.001,008.803.36L
2026-03-18990.001,025.75981.151,013.855.94L
2026-03-17981.95994.45969.00986.154.61L
2026-03-16953.10984.65946.35976.506.73L
2026-03-13998.001,005.40938.00953.056.47L
2026-03-121,030.051,034.20991.001,008.856.62L
2026-03-111,022.001,031.101,004.501,014.005.68L

Frequently Asked Questions

About

Sai Life Sciences Limited, listed on the NSE as SAILIFE, is a contract research, development, and manufacturing organization (CRDMO) specializing in pharmaceutical and biotechnology services. The company offers a range of services including discovery, development, and commercial-scale manufacturing of new chemical entities (NCEs) and small molecules for global pharma and biotech clients. Notably, Sai Life Sciences is recognized as one of India's fastest-growing CRDMOs in terms of revenue and EBITDA growth from FY22 to FY24.

BOARD OF DIRECTORS
Krishnamraju Kanumuri
Managing Director
Mitesh Daga
Executive Director
DEPARTED
Sivaramakrishnan Chittor
Additional Director